Eosinophils are a Major Source of Interleukin-31 in Bullous Pemphigoid

被引:59
|
作者
Ruedrich, Urda [1 ]
Gehring, Manuela [1 ]
Papakonstantinou, Eleni [1 ]
Illerhaus, Anja [2 ]
Engmann, Judith [1 ]
Kapp, Alexander [1 ]
Hartmann, Karin [3 ]
Meyer, N. Helge [4 ]
Gibbs, Bernhard F. [4 ]
Raap, Ulrike [1 ,4 ]
机构
[1] Hannover Med Sch, Dept Dermatol & Allergol, Hannover, Germany
[2] Univ Cologne, Dept Dermatol, Cologne, Germany
[3] Med Univ Lubeck, Dept Dermatol & Allergol, Lubeck, Germany
[4] Carl von Ossietzky Univ Oldenburg, Dept Human Med, Dermatol & Allergol, Oldenburg, Germany
关键词
bullous pemphigoid; IL-31; itch; pruritus; eosinophils; IL-31; SERUM-LEVELS; T-CELLS; ATOPIC-DERMATITIS; DISEASE-ACTIVITY; CORRELATE; RECEPTOR; EXPRESSION; PRURITUS; SKIN; SEVERITY;
D O I
10.2340/00015555-2951
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Bullous pemphigoid (BP) is characterized by substantial skin and blood eosinophilia as well as intensive pruritus. Since the pruritogenic cytokine interleukin (IL)-31 is increased in inflammatory skin diseases the aim of this study was to determine whether IL-31 plays a role in BP. Using immunofluorescence, IL-31 expression was analysed in eosinophils derived from blister fluids and skin from patients with BP and IL-31 levels in blister fluids, serum and culture supernatants were determined by enzyme-linked immunoassay (ELISA). High levels of IL-31 expression were observed in BP blister fluids, but they were only marginally elevated in BP serum compared with healthy controls. Eosinophils from either BP blister fluids or skin biopsies showed strong expression of IL-31. Furthermore, peripheral blood eosinophils from patients with BP, but not healthy controls, released high levels of IL-31, reflecting those in blister fluids. In conclusion, eosinophils are a major source of IL-31 in BP and this cytokine may contribute to itch in patients with BP.
引用
收藏
页码:766 / 771
页数:6
相关论文
共 50 条
  • [1] Serum levels and tissue expression of interleukin-31 in dermatitis herpetiformis and bullous pemphigoid
    Bonciani, Diletta
    Quintarelli, Lavinia
    Del Bianco, Elena
    Bianchi, Beatrice
    Caproni, Marzia
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2017, 87 (02) : 210 - 212
  • [2] Eosinophils in bullous pemphigoid
    Jones, Virginia A.
    Patel, Payal M.
    Amber, Kyle T.
    PANMINERVA MEDICA, 2021, 63 (03) : 368 - 378
  • [3] Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis
    Furue, M.
    Yamamura, K.
    Kido-Nakahara, M.
    Nakahara, T.
    Fukui, Y.
    ALLERGY, 2018, 73 (01) : 29 - 36
  • [4] Eosinophils are the major source of eotaxin and MCP-4 in bullous pemphigoid disease: Storage and association with granules.
    Lamkhioued, B
    Allakhverdi, Z
    Renzi, P
    Luster, A
    Hamid, Q
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (01) : S52 - S52
  • [5] Eosinophils, Basophils, and Neutrophils in Bullous Pemphigoid
    Limberg, Maren M.
    Weihrauch, Tobias
    Gray, Natalie
    Ernst, Nancy
    Hartmann, Karin
    Raap, Ulrike
    BIOMOLECULES, 2023, 13 (07)
  • [6] Interleukin-31 and interleukin-31 receptor: New therapeutic targets for atopic dermatitis
    Nakashima, Chisa
    Otsuka, Atsushi
    Kabashima, Kenji
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (04) : 327 - 331
  • [7] Targeting Interleukin-31 in Prurigo
    Metz, Martin
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (17): : 1619 - 1620
  • [8] Interleukin-31 and Pruritic Skin
    Furue, Masutaka
    Furue, Mihoko
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (09)
  • [9] The association of interleukin-31 polymorphisms with interleukin-31 serum levels and risk of systemic lupus erythematosus
    Huang, Hua-Tuo
    Chen, Jian-Ming
    Guo, Jing
    Lan, Yan
    Wei, Ye-Sheng
    RHEUMATOLOGY INTERNATIONAL, 2016, 36 (06) : 799 - 805
  • [10] Eosinophils as putative therapeutic targets in bullous pemphigoid
    Simon, Dagmar
    Borradori, Luca
    Simon, Hans-Uwe
    EXPERIMENTAL DERMATOLOGY, 2017, 26 (12) : 1187 - 1192